II. Medical treatment of inflammatory bowel disease.
作者信息
Gray G M
出版信息
Calif Med. 1973 Nov;119(5):21-4.
Abstract
摘要
相似文献
1
II. Medical treatment of inflammatory bowel disease.二、炎症性肠病的医学治疗
Calif Med. 1973 Nov;119(5):21-4.
2
[Immunomodulation treatment of inflammatory bowel disease].
Tidsskr Nor Laegeforen. 1984 Jan 30;104(3):153-4.
3
Inflammatory bowel disease. Part II.
Proc Annu Meet Med Sect Am Counc Life Insur. 1978:41-9.
4
The drug therapy of ulcerative colitis and of Crohn's disease.
Semin Drug Treat. 1974 Spring;3(4):339-49.
5
Pharmacotherapy of inflammatory bowel disease.炎症性肠病的药物治疗
J Maine Med Assoc. 1976 Jul;67(7):206-14.
6
Sulphasalazine in inflammatory bowel disease: recent advances.柳氮磺胺吡啶在炎症性肠病中的应用：最新进展
N Z Med J. 1986 Oct 8;99(811):757-9.
7
[An approach to the medical management of inflammatory bowel disease (author's transl)].
Przegl Lek. 1981;38(6):499-505.
8
[Recurrence-preventive (remission preserving) therapy of chronic inflammatory bowel diseases].[慢性炎症性肠病的预防复发（维持缓解）治疗]
Dtsch Med Wochenschr. 1998 Jan 23;123(4):85-7. doi: 10.1055/s-2007-1023902.
9
[Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].[5-氨基水杨酸治疗慢性炎症性肠病]
Internist (Berl). 1987 Jan;28(1):14-20.
10
[Salazosulfapyridine: old and new therapy concepts in inflammatory bowel diseases].柳氮磺胺吡啶：炎症性肠病的新旧治疗理念
Dtsch Med Wochenschr. 1985 Nov 22;110(47):1827-9. doi: 10.1055/s-2008-1069097.
引用本文的文献
1
Liquid chromatography-mass spectrometry for measuring deoxythioguanosine in DNA from thiopurine-treated patients.液相色谱-质谱联用技术用于测定硫嘌呤治疗患者DNA中的脱氧硫鸟苷。
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Aug 15;1028:175-180. doi: 10.1016/j.jchromb.2016.06.017. Epub 2016 Jun 15.
本文引用的文献
1
A critical analysis of the use of salicylazosulfapyridine in chronic ulcerative colitis.柳氮磺胺吡啶在慢性溃疡性结肠炎中的应用批判性分析。
Ann Intern Med. 1959 Nov;51:879-89. doi: 10.7326/0003-4819-51-5-879.
2
Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis.大肠克罗恩病（局限性肠炎）及其与溃疡性结肠炎的鉴别
Gut. 1960 Jun;1(2):87-105. doi: 10.1136/gut.1.2.87.
3
CARCINOMA OF THE COLON IN ULCERATIVE COLITIS.溃疡性结肠炎中的结肠癌
Cancer. 1964 May;17:657-65. doi: 10.1002/1097-0142(196405)17:5<657::aid-cncr2820170515>3.0.co;2-7.
4
Systemic and local corticosteroid therapy in ulcerative colitis.溃疡性结肠炎的全身和局部皮质类固醇治疗。
Br Med J. 1960 Feb 13;1(5171):464-7. doi: 10.1136/bmj.1.5171.464.
5
Granulomatous diseases of the intestine.肠道肉芽肿性疾病。
Lancet. 1959 Nov 7;2(7106):745-9. doi: 10.1016/s0140-6736(59)90854-2.
6
Cortisone in ulcerative colitis; preliminary report on a therapeutic trial.可的松治疗溃疡性结肠炎；一项治疗试验的初步报告
Br Med J. 1954 Aug 14;2(4884):375-8. doi: 10.1136/bmj.2.4884.375.
7
Toxic dilatation of colon (toxic megacolon): etiology, treatment and prognosis in 42 patients.
Medicine (Baltimore). 1969 May;48(3):229-50. doi: 10.1097/00005792-196905000-00003.
8
Azathioprine treatment of ulcerative colitis, granulomatous colitis and regional enteritis.硫唑嘌呤治疗溃疡性结肠炎、肉芽肿性结肠炎和局限性肠炎。
Am J Dig Dis. 1971 Apr;16(4):327-32. doi: 10.1007/BF02235208.
9
Azathioprine: an adjunct to surgical therapy of granulomatous enteritis.硫唑嘌呤：肉芽肿性肠炎手术治疗的辅助药物。
Ann Surg. 1970 Oct;172(4):618-26. doi: 10.1097/00000658-197010000-00008.
10
Cancer risk and life expectancy of children with ulcerative colitis.溃疡性结肠炎患儿的癌症风险和预期寿命。
N Engl J Med. 1971 Jul 1;285(1):17-21. doi: 10.1056/NEJM197107012850103.
Zotero 插件